Table 2 TRF for RVO other than MTHFR polymorphisms.

From: Thrombophilic risk factors for retinal vein occlusion

HH

PT G20210A

Lupic anticoagulant

Antiphospholipid antibody

FV Leiden G1691A

PAI 1 4 G/4 G and 4 G/5 G

HTZ

HTZ

HOMO

HTZ

26 (43.3%)

1 (1.7%)

5 (8.3%)

0 (0%)

1 (1.7%)

7 (11.7%)

33 (55%)

  1. TRF = thrombophilic risk factors; RVO = retinal vein occlusion; MTFRH = methylene tetrahydrofolate reductase; HH = Hyperhomocysteinemia (homocysteinemia > 15 µmol/L); FV Leiden = Factor V G1691A; PT G20210A = allele mutation of the factor II/prothombin gene; PAI-1 = plasminogen activator inhibitor-1 mutations 4 G/4 G and 4 G/5 G. HTZ = heterozygosity; HOMO = Homozygosity. Results are expressed in number of subjects and percentage.
Back to article page